Quest Pharmatech Inc.
Records under this name other than the patents Quest Pharmatech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,697,079 | Ige Antibodies for the Treatment of Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 8,945,566 | METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASE Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,392,444 | Tumor antigen specific antibodies and TLR3 stimulation to enhance the performance of checkpoint interference therapy of cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,975,163 | Methods of increasing delivery of anti-cancer agents to targets Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,758,725 | Perylenequinone derivatives and uses thereof Lapsed on the fee record Ended Jun 24, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 24, 2026 | From the USPTO record |
| US 8,747,811 | Perylenequinone derivatives and uses thereof Lapsed on the fee record Ended Jun 10, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 10, 2026 | From the USPTO record |
| US 7,659,244 | Rapamycin peptides conjugates: synthesis and uses thereof Term ended Term ended May 27, 2026 · From the USPTO record | Term ended | Term ended May 27, 2026 | From the USPTO record |
| US 8,506,931 | Perylenequinone derivatives and uses thereof Lapsed on the fee record Ended Aug 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2025 | From the USPTO record |
| US 8,454,991 | Method and device for photodynamic therapy Lapsed on the fee record Ended Jun 4, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 4, 2025 | From the USPTO record |
| US 7,147,850 | Therapeutic Binding Agents Against MUC-1 Antigen and Methods for Their Use Formerly held Term ended Ended no later than Oct 13, 2021 · Low confidence | Term ended | Ended no later than Oct 13, 2021 | Low confidence |